Gene: MAP3K14
Official Full Name: mitogen-activated protein kinase kinase kinase 14provided by HGNC
Gene Summary: This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11046 | MAP3K14 Knockout cell line (HeLa) | Human | MAP3K14 | 1:3~1:6 | Negative | Online Inquiry |
KO11047 | MAP3K14 Knockout cell line (HCT 116) | Human | MAP3K14 | 1:2~1:4 | Negative | Online Inquiry |
KO11048 | MAP3K14 Knockout cell line (HEK293) | Human | MAP3K14 | 1:3~1:6 | Negative | Online Inquiry |
KO11049 | MAP3K14 Knockout cell line (A549) | Human | MAP3K14 | 1:3~1:4 | Negative | Online Inquiry |
MAP3K14 Gene Knockout Cell Lines are a specialized set of genetically modified cell lines that lack functional MAP3K14 gene expression. The MAP3K14 gene plays a critical role in the regulation of the NF-κB signaling pathway, which is pivotal in diverse biological processes including inflammation, immune responses, and cell survival. By employing CRISPR-Cas9 technology to create these knockout cell lines, researchers can effectively study the downstream effects of MAP3K14 deficiency, facilitating a deeper understanding of its biological roles and implications in disease mechanisms.
The mechanisms through which these knockout cell lines operate involve the abrogation of signal transduction pathways normally activated by MAP3K14, allowing researchers to observe the resulting phenotypic changes, alterations in gene expression, and variations in cellular behavior. This enables precise experimental designs to isolate the functions of MAP3K14, which is especially useful in cancer research, autoimmune diseases, and therapeutic development.
The scientific importance of MAP3K14 Gene Knockout Cell Lines is underscored by their application in preclinical research and drug discovery, where they serve as invaluable tools for elucidating the role of MAP3K14 in pathophysiology. Their specific advantages include high fidelity in gene editing, a well-characterized background, and reproducibility across multiple experiments, making them a superior alternative to other models such as siRNA or overexpression systems that can produce inconsistent results.
Researchers and clinicians benefit greatly from utilizing MAP3K14 Gene Knockout Cell Lines as they provide insights into gene function and regulatory mechanisms critical for developing targeted therapies. These cell lines represent essential resources for those seeking to innovate within areas of cancer biology and therapeutic target identification.
Our company specializes in providing high-quality, precision-engineered biological products, such as the MAP3K14 Gene Knockout Cell Lines, backed by extensive expertise in genetic modification techniques and a commitment to empowering discovery in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.